Aurora Cannabis Inc (TSE:ACB) has earned an average rating of “Buy” from the six research firms that are presently covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a hold rating and three have assigned a buy rating to the company. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is C$13.80.
A number of equities analysts have recently issued reports on ACB shares. Eight Capital dropped their target price on Aurora Cannabis from C$17.00 to C$15.00 in a report on Wednesday, January 9th. Seaport Global Securities reaffirmed a “neutral” rating on shares of Aurora Cannabis in a report on Thursday, February 21st. Cowen reaffirmed an “outperform” rating and set a C$14.00 price target on shares of Aurora Cannabis in a report on Tuesday, March 5th. Jefferies Financial Group reiterated a “buy” rating and issued a C$12.00 price objective on shares of Aurora Cannabis in a research report on Monday, February 25th. Finally, Bank of America reiterated a “buy” rating and issued a C$15.00 price objective on shares of Aurora Cannabis in a research report on Wednesday.
Shares of ACB opened at C$12.03 on Wednesday. Aurora Cannabis has a 1 year low of C$5.29 and a 1 year high of C$16.24. The company has a quick ratio of 1.89, a current ratio of 3.31 and a debt-to-equity ratio of 8.08. The company has a market capitalization of $12.17 billion and a PE ratio of -121.52.
Aurora Cannabis (TSE:ACB) last issued its earnings results on Monday, February 11th. The company reported C($0.05) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of C($0.06) by C$0.01. The company had revenue of C$54.18 million during the quarter, compared to analyst estimates of C$52.13 million. As a group, equities research analysts expect that Aurora Cannabis will post 0.0299747682090031 earnings per share for the current year.
About Aurora Cannabis
Aurora Cannabis Inc is a Canada-based company engaged in the production and distribution of medical cannabis. The Company is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis, and hemp production, derivatives, home cultivation, wholesale and retail distribution.
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.